Home Cart Sign in  
Chemical Structure| 908099-97-8
Chemical Structure| 908099-97-8

*Storage: Keep in dark place,Inert atmosphere,Room temperature.

*Shipping: Normal

2-Methoxy-4-methylpyrimidin-5-amine

CAS No.: 908099-97-8

4.5 *For research use only!

Cat. No.: A238631 Purity: 98%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
100mg łÍ§¶Ê Inquiry In Stock Login
250mg łÿË¶Ê In Stock Inquiry Login
1g łÇÍÍ¶Ê Inquiry Inquiry Login

Please Login or Create an Account to: See VIP prices and availability

  • 100mg

    łÍ§¶Ê

  • 250mg

    łÿ˶Ê

  • 1g

    łÇÍͶÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online technical Q&A
Product Citations

Product Details of [ 908099-97-8 ]

CAS No. :908099-97-8
Formula : C6H9N3O
M.W : 139.16
MDL No. :MFCD19205907
InChI Key :XBZVMOAYTYONPW-UHFFFAOYSA-N
Pubchem ID :55281910

Safety of [ 908099-97-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 908099-97-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.33
Num. rotatable bonds 1
Num. H-bond acceptors 3.0
Num. H-bond donors 1.0
Molar Refractivity 37.89
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

61.03 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.4
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.23
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.38
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.52
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.59
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.42

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.23
Solubility 8.28 mg/ml ; 0.0595 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.07
Solubility 11.8 mg/ml ; 0.0848 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.78
Solubility 2.31 mg/ml ; 0.0166 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.99 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.94
 

Related Products

Technical Information

Categories

Related Functional Groups of
[ 908099-97-8 ]

Ethers

Chemical Structure| 944901-04-6

A284294[ 944901-04-6 ]

(2-Methoxypyrimidin-4-yl)methanamine

Similarity: 0.89

Chemical Structure| 2044706-05-8

A103092[ 2044706-05-8 ]

(2-Methoxypyrimidin-4-yl)methanamine dihydrochloride

Similarity: 0.88

Chemical Structure| 56621-89-7

A136098[ 56621-89-7 ]

5-Amino-2-methoxypyrimidine

Similarity: 0.83

Chemical Structure| 14001-60-6

A163081[ 14001-60-6 ]

2-Methoxy-4-methylpyrimidine

Similarity: 0.83

Chemical Structure| 14001-61-7

A120936[ 14001-61-7 ]

2-Methoxy-4,6-dimethylpyrimidine

Similarity: 0.78

Amines

Chemical Structure| 944901-04-6

A284294[ 944901-04-6 ]

(2-Methoxypyrimidin-4-yl)methanamine

Similarity: 0.89

Chemical Structure| 2044706-05-8

A103092[ 2044706-05-8 ]

(2-Methoxypyrimidin-4-yl)methanamine dihydrochloride

Similarity: 0.88

Chemical Structure| 56621-89-7

A136098[ 56621-89-7 ]

5-Amino-2-methoxypyrimidine

Similarity: 0.83

Chemical Structure| 73418-86-7

A628073[ 73418-86-7 ]

2-Ethoxypyrimidin-5-amine

Similarity: 0.78

Chemical Structure| 35733-53-0

A151057[ 35733-53-0 ]

2,4-Dimethylpyrimidin-5-amine

Similarity: 0.72

Related Parent Nucleus of
[ 908099-97-8 ]

Pyrimidines

Chemical Structure| 944901-04-6

A284294[ 944901-04-6 ]

(2-Methoxypyrimidin-4-yl)methanamine

Similarity: 0.89

Chemical Structure| 2044706-05-8

A103092[ 2044706-05-8 ]

(2-Methoxypyrimidin-4-yl)methanamine dihydrochloride

Similarity: 0.88

Chemical Structure| 56621-89-7

A136098[ 56621-89-7 ]

5-Amino-2-methoxypyrimidine

Similarity: 0.83

Chemical Structure| 14001-60-6

A163081[ 14001-60-6 ]

2-Methoxy-4-methylpyrimidine

Similarity: 0.83

Chemical Structure| 14001-61-7

A120936[ 14001-61-7 ]

2-Methoxy-4,6-dimethylpyrimidine

Similarity: 0.78